Fengabine

This classification denotes an antidepressant agent with the molecular formula C17H17Cl2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YQG0NJI5A7, chemically known as sl 79,229-00 but generally known as fengabine, which bears US NIH Compound Identifier 5362066. European Medicines Agency schedules Fengabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07563MIG. The term FENGABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). FENGABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fengabine under HS 29252900 and SITC 51482. As of Q4 2014, FENGABINE remains the US FDA Preferred Term for this commodity. Fengabine bears US NLM identifiers UMLS ID C0060170 and NCI Concept Code C72778. SMILES: Clc1c(C(=C2\C=C(Cl)C=CC2=O)/NCCCC)cccc1.